Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer

BACKGROUND: Alpha-fetoprotein-producing gastric cancer (AFPGC) poses a therapeutic challenge worldwide because of its poor prognosis. This study aimed to evaluate the efficacy and safety of antiangiogenic drug apatinib in advanced AFPGC in a real-world setting. METHODS: From September 2015 to Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ningning, Bai, Chunmei, Zhang, Ruixing, Ma, Liwen, Ren, Xiubao, Zhang, Junping, Fu, Zhanzhao, Zhao, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777135/
https://www.ncbi.nlm.nih.gov/pubmed/33383486
http://dx.doi.org/10.1016/j.tranon.2020.101004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777135/
https://www.ncbi.nlm.nih.gov/pubmed/33383486
http://dx.doi.org/10.1016/j.tranon.2020.101004

Ejemplares similares